Screener
Abbott ABT Cumulative Cost Basis
Cumulative Cost Basis at other companies
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.
The source filing: Abbott’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050134
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Prepaid expenses and other receivables | 3,000 | 2,640 |
| Total Current Assets | 24,517 | 25,996 |
| Investments | 1,111 | 918 |
| Property and equipment, at cost | 26,469 | 25,222 |
| Less: accumulated depreciation and amortization | 13,657 | 13,406 |
| Net property and equipment | 12,812 | 11,816 |
| Intangible assets, net of amortization | 17,211 | 5,526 |
| Goodwill | 35,244 | 24,035 |
Item 1. Financial Statements and Supplementary Data
FAQ
- What is Abbott's cumulative cost basis?
- Abbott (ABT) reported cumulative cost basis of $26.47B in Q2 2026.
- How has Abbott's cumulative cost basis changed year-over-year?
- Abbott's cumulative cost basis increased by 8.2% year-over-year, from $24.47B to $26.47B.
- What is the long-term trend for Abbott's cumulative cost basis?
- Over 5 years (2020 to 2025), Abbott's cumulative cost basis has grown at a 6.1% compound annual growth rate (CAGR), from $18.79B to $25.22B.
Ask your AI about Abbott's cumulative cost basis.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude